Ken MacLeod
Director/Board Member bij SEQUANA MEDICAL N.V.
Profiel
Ken MacLeod is currently a Director at JenaValve Technology, Inc., a Director at Oxular Ltd., and a Non-Executive Director at Sequana Medical NV.
He has formerly held positions as a Director at On-X Life Technologies, Inc., Pharming Group NV, and Cryogenics, Inc. Dr. MacLeod received an undergraduate degree from The University of Manchester and a doctorate degree from The University of York.
Actieve functies van Ken MacLeod
Bedrijven | Functie | Begin |
---|---|---|
SEQUANA MEDICAL N.V. | Director/Board Member | 01-06-2023 |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Director/Board Member | 05-04-2023 |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
Eerdere bekende functies van Ken MacLeod
Bedrijven | Functie | Einde |
---|---|---|
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX. | Director/Board Member | - |
Cryogenics, Inc.
Cryogenics, Inc. Oilfield Services/EquipmentIndustrial Services Cryogenics, Inc. manufactures equipment for the petrochemical industry. | Director/Board Member | - |
PHARMING GROUP N.V. | Director/Board Member | - |
Opleiding van Ken MacLeod
The University of Manchester | Undergraduate Degree |
The University of York | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PHARMING GROUP N.V. | Health Technology |
SEQUANA MEDICAL N.V. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX. | Health Technology |
Cryogenics, Inc.
Cryogenics, Inc. Oilfield Services/EquipmentIndustrial Services Cryogenics, Inc. manufactures equipment for the petrochemical industry. | Industrial Services |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |